The efficacy benefits of biphasic insulin aspart formulation (BIAsp 30) in patients with diabetes mellitus have been reported in several studies. BIAsp 30 has been shown to be more effective in ...

A trial conducted in eight countries, including India has shown that using biphasic BIAsp 30 insulin can lead to significant clinical improvements and greater patient satisfaction. A trial ...